David Mulham Mulham - 27 Feb 2025 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Mar 2025, 12:12:14 UTC
Prior SEC filing
11 Feb 2025
Next SEC filing
11 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joshua Foukas, Attorney-in-Fact

Key filing fact

David Mulham Mulham filed Form 4 for USANA HEALTH SCIENCES INC (USNA) on 03 Mar 2025.

Key facts

  • This page summarizes David Mulham Mulham's Form 4 filing for USANA HEALTH SCIENCES INC (USNA).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 03 Mar 2025, 12:12.

Change

  • Previous filing in this sequence was filed on 11 Feb 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

USNA transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+18,641
Change %
+133%
Price
$0.000000
Shares after
32,671
Date
27 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
18,641
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

Footnote F2

On February 27th 2025, the reporting person was granted restricted stock units, vesting at 25% on each 27th of February thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .